
Preboplatin 150mg Injection
Marketer
Premedium Pharmaceuticals Pvt Ltd
Salt Composition
Carboplatin (150mg)
Overview Preboplatin 150mg Injection
This injectable formulation, Preboplatin 150mg, combats ovarian and small-cell lung cancers by inhibiting cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are individually determined by your physician, depending on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse events. While therapeutic effects might take weeks or months to manifest, discontinue use only under your doctor's instruction. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. A reduction in blood cell counts (red and white blood cells) is possible, increasing infection and bleeding risks. Report any fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitoring blood cell counts, alongside heart, liver function, and uric acid levels, are essential. Allergic reactions (skin rash, itching, respiratory distress) necessitate immediate medical attention. Inform your healthcare provider about all other medications you are taking, as interactions may occur. Preboplatin 150mg is contraindicated during pregnancy and breastfeeding; reliable contraception is vital for both partners throughout treatment.
Uses of Preboplatin 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Preboplatin 150mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Preboplatin 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Preboplatin 150mg Injection:
Administering this medication will be handled by your physician or their qualified staff; self-medication is strictly prohibited.
How Preboplatin 150mg Injection works:
The anti-cancer drug, Preboplatin 150mg Injection, disrupts the DNA and RNA of cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Preboplatin 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering 150mg Preboplatin Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use only when the potential advantages outweigh the known hazards. Patient consultation with their doctor is essential.
Breast feedingUNSAFE
Administering 150mg Preboplatin injections while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Preboplatin 150mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Patients with impaired kidney function should receive Preboplatin 150mg Injection cautiously, potentially requiring dose modification. Severe kidney disease contraindicates its use. Your physician should be consulted. Regular assessment of renal function is advisable during treatment.
LiverSAFE IF PRESCRIBED
The use of 150mg Preboplatin Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Preboplatin 150mg Injection :
Omitting a scheduled dose of Preboplatin 150mg Injection necessitates contacting your physician.
Facts to Know About Preboplatin 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Platinum-based anticancer agents |
